SURGERX

Welcome to the Brand page for “SURGERX”, which is offered here for Hydrogel for medical purposes; natural biomaterial for medical purposes; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; natural intraoperative biomaterial for delivery of immunotherapy;artificial biomaterial for medical purposes; artificial intraoperative biomaterial for delivery of immunotherapy;.

Its status is currently believed to be active. Its class is unavailable. “SURGERX” is believed to be currently owned by “SURGE THERAPEUTICS, INC.”


Owner:
SURGE THERAPEUTICS, INC.
Owner Details
Description:
Hydrogel for medical purposes; Natural biomaterial for medical purposes; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; Natural intraoperative biomaterial for delivery of immunotherapy;Artificial biomaterial for medical purposes; Artificial intraoperative biomaterial for delivery of immunotherapy;
Categories: HYDROGEL MEDICAL PURPOSES